Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Edwards Lifesciences Corporation
  6. News
  7. Summary
    EW   US28176E1082

EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
Real-time Estimate Cboe BZX  -  11:18:35 2023-02-08 am EST
79.29 USD   -0.94%
02/07North American Morning Briefing: Caution Likely -2-
DJ
02/06Raymond James Downgrades Edwards Lifesciences to Market Perform From Outperform
MT
02/01Wells Fargo Raises Edwards Lifesciences' Price Target to $97 From $96, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Morgan Stanley Adjusts Price Target on Edwards Lifesciences to $98 From $108, Reiterates Overweight Rating

10/28/2022 | 01:06pm EST
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about EDWARDS LIFESCIENCES CORPORATION
02/07North American Morning Briefing: Caution Likely -2-
DJ
02/06Raymond James Downgrades Edwards Lifesciences to Market Perform From Outperform
MT
02/01Wells Fargo Raises Edwards Lifesciences' Price Target to $97 From $96, Maintains Overwe..
MT
02/01Evercore ISI Raises Edwards Lifesciences' Price Target to $84 From $82, Maintains Outpe..
MT
02/01Bernstein Downgrades Edwards Lifesciences to Underperform From Outperform, Cuts Price T..
MT
02/01Canaccord Genuity Adjusts Edwards Lifesciences Price Target to $76 From $68, Maintains ..
MT
02/01Truist Securities Adjusts Price Target on Edwards Lifesciences to $86 From $85, Maintai..
MT
01/31Transcript : Edwards Lifesciences Corporation, Q4 2022 Earnings Call, Jan 31,..
CI
01/31Edwards Lifesciences Q4 Adjusted Profit, Sales Advance; Sets Q1 Guidance, Reiterates 20..
MT
01/31Edwards Lifesciences : Q4 Earnings Snapshot
AQ
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
More recommendations
Financials (USD)
Sales 2022 5 365 M - -
Net income 2022 1 497 M - -
Net cash 2022 435 M - -
P/E ratio 2022 33,5x
Yield 2022 -
Capitalization 49 486 M 49 486 M -
EV / Sales 2022 9,14x
EV / Sales 2023 8,31x
Nbr of Employees 15 700
Free-Float 95,1%
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 80,04 $
Average target price 89,90 $
Spread / Average Target 12,3%
EPS Revisions
Managers and Directors
Michael A. Mussallem Chairman & Chief Executive Officer
Bernard J. Zovighian President
Scott B. Ullem Chief Financial Officer & Vice President
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
Nicholas J. Valeriani Independent Director
Sector and Competitors
1st jan.Capi. (M$)
EDWARDS LIFESCIENCES CORPORATION7.28%49 486
THERMO FISHER SCIENTIFIC5.89%229 789
DANAHER CORPORATION0.22%193 728
INTUITIVE SURGICAL, INC.-4.63%89 427
BOSTON SCIENTIFIC CORPORATION3.00%68 880
SIEMENS HEALTHINEERS AG14.27%63 931